Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $120,310 - $299,186
22,700 Added 667.65%
26,100 $292,000
Q2 2024

Aug 14, 2024

SELL
$5.25 - $6.73 $9,450 - $12,114
-1,800 Reduced 34.62%
3,400 $18,000
Q1 2024

May 15, 2024

BUY
$6.03 - $7.86 $18,693 - $24,366
3,100 Added 147.62%
5,200 $35,000
Q4 2023

Feb 14, 2024

SELL
$4.46 - $7.07 $10,704 - $16,968
-2,400 Reduced 53.33%
2,100 $14,000
Q3 2023

Nov 14, 2023

SELL
$5.01 - $7.09 $64,128 - $90,752
-12,800 Reduced 73.99%
4,500 $22,000
Q2 2023

Aug 14, 2023

SELL
$6.54 - $10.58 $92,214 - $149,178
-14,100 Reduced 44.9%
17,300 $125,000
Q1 2023

May 15, 2023

SELL
$7.33 - $10.63 $49,111 - $71,221
-6,700 Reduced 17.59%
31,400 $265,000
Q4 2022

Feb 14, 2023

SELL
$7.7 - $11.21 $749,980 - $1.09 Million
-97,400 Reduced 71.88%
38,100 $322,000
Q3 2022

Nov 14, 2022

BUY
$9.82 - $16.49 $1.18 Million - $1.99 Million
120,400 Added 797.35%
135,500 $1.4 Million

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $381M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.